Ignite Creation Date:
2024-05-06 @ 1:32 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01831726
Status:
COMPLETED
Last Update Posted:
2017-03-20
First Post:
2013-04-11
Brief Title:
Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Sponsor:
Organization:
Novartis